Nicole West
Ophthalmic Plastic and Reconstructive Surgery · Liberty, MONPI 1184129660
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,909 of the $4,832 with a category attached, or 80.9%. 20 manufacturers reported payments, led by Amgen at 26.6% of the total. Reporting peaked in 2022 at $2,073 and has fallen 70.5% since, to $612 in 2025.
Across 64 payments — averaging $75.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$762
- Bausch & Lomb Americas Inc.$304
- AbbVie$155
- Glaukos Corporation$142
- plus $955 from 14 others
What the payments were for
- Travel & lodging$92319%
- Food & beverage$3,90981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $1,286 |
| Johnson & Johnson Surgical Vision, Inc. | 9 | $1,228 |
| Alcon | 7 | $762 |
| Bausch & Lomb Americas Inc. | 6 | $304 |
| AbbVie | 2 | $155 |
| Glaukos Corporation | 1 | $142 |
| Astellas Pharma US Inc | 1 | $121 |
| Eyepoint US, Inc. | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 1 | $113 |
| Ocular Therapeutix, Inc. | 1 | $111 |
| Sight Sciences, Inc. | 1 | $107 |
| Ivantis, Inc | 1 | $97 |
| Oyster Point Pharma, Inc. | 3 | $74 |
| Dompe US, Inc. | 3 | $64 |
| Harrow Eye, LLC | 1 | $35 |
| Genentech USA, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$947
- Tecnis IOL$923
- Tecnis Simplicity$923
- VERITAS Vision System$923
- Clareon$389
- iStent Trabecular Micro-Bypass System Model iS3$142
- AcrySof IQ PanOptix$138
- DURYSTA$125
- Izervay$121
- YUTIQ$120
- TORIC$117
- EYLEA$113
- DEXTENZA$111
- Hydrus Microstent$110
- MIEBO$110
- XIIDRA$110
- AcrySof IQ VIVITY IOL$107
- OMNI(R) SURGICAL SYSTEM (US)$107
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 146 | $1,404 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $282 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Liberty
- Michael ChappellKansas City$43K
- Tiffany HoSaint Louis$1K
- Robi MaamariSaint Louis$1K
- Christine RyuSaint Louis$711
- Carisa PetrisColumbia$472
- Maria Valenzuela-ArellanoColumbia$442
- Rocio BentivegnaSaint Louis$150
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.